Myriad Genetics Inc (MYGN): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$45.30M
Year ended 2022-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $45.30M | +151.7% | 2023-03-01, From 2022-01-01 |
| 2021-12-31 | $18.00M | n/a | 2023-03-01, From 2021-01-01 |
| No annual figure between 2020-06-30 and 2021-12-31. | |||
| 2020-06-30 | $10.20M | +18.6% | 2023-03-01, From 2019-07-01 |
| 2019-06-30 | $8.60M | +2.4% | 2022-02-25, From 2018-07-01 |
| 2018-06-30 | $8.40M | +37.7% | 2020-08-13, From 2017-07-01 |
| 2017-06-30 | $6.10M | +22.0% | 2019-08-13, From 2016-07-01 |
| 2016-06-30 | $5.00M | -79.1% | 2018-08-24, From 2015-07-01 |
| 2015-06-30 | $23.90M | +67.1% | 2017-08-09, From 2014-07-01 |
| 2014-06-30 | $14.30M | +25.4% | 2016-08-10, From 2013-07-01 |
| 2013-06-30 | $11.40M | +21.2% | 2015-08-12, From 2012-07-01 |
| 2012-06-30 | $9.41M | +148.1% | 2014-08-13, From 2011-07-01 |
| 2011-06-30 | $3.79M | -52.0% | 2013-08-14, From 2010-07-01 |
| 2010-06-30 | $7.89M | +4.9% | 2012-08-15, From 2009-07-01 |
| 2009-06-30 | $7.53M | n/a | 2011-08-15, From 2008-07-01 |